Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.
70 - 78
Multiple Sclerosis and Related Disorders
MetadataShow full item record
Trials of anti-inflammatory therapies in non-relapsing progressive multiple sclerosis (MS) have been stubbornly negative except recently for an anti-CD20 therapy in primary progressive MS and a S1P modulator siponimod in secondary progressive MS. We argue that this might be because trials have been too short and have focused on assessing neuronal pathways, with insufficient reserve capacity, as the core component of the primary outcome. Delayed neuroaxonal degeneration primed by prior inflammation is not expected to respond to disease-modifying therapies targeting MS-specific mechanisms. However, anti-inflammatory therapies may modify these damaged pathways, but with a therapeutic lag that may take years to manifest. Based on these observations we propose that clinically apparent neurodegenerative components of progressive MS may occur in a length-dependent manner and asynchronously. If this hypothesis is confirmed it may have major implications for the future design of progressive MS trials.
AuthorsGiovannoni, G; Cutter, G; Pia-Sormani, M; Belachew, S; Hyde, R; Koendgen, H; Knappertz, V; Tomic, D; Leppert, D; Herndon, R; Wheeler-Kingshott, CAM; Ciccarelli, O; Selwood, D; di Cantogno, EV; Ben-Amor, A-F; Matthews, P; Carassiti, D; Baker, D; Schmierer, K
- College Publications 
Showing items related by title, author, creator and subject.
Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? Cerqueira, JJ; Compston, DAS; Geraldes, R; Rosa, MM; Schmierer, K; Thompson, A; Tinelli, M; Palace, J (BMJ Publishing Group, 2018-04-04)
Maggiore, Cosimo (Queen Mary University of London, 2013)One of the pathological features of multiple sclerosis (MS) is the presence of a long lived chronic inflammation in the central nervous system (CNS) with presence of oligoclonal IgG and IgM bands (OCBs) in the cerebrospinal ...
Sclanders, Michelle (Queen Mary University of London, 2012-04)Disease progression in Multiple Sclerosis (MS), an autoimmune disease of the CNS, is widely accepted to be due to persistent myelin loss (demyelination) coinciding with lost nerve cells and nerve fibres (neuroaxonal loss). ...